Allograft vs. autograft for chronic acromioclavicular joint instability: a systematic review and meta-analysis of outcomes and complications

Résumé fourni par la source

Background: Chronic acromioclavicular joint (ACJ) instability is commonly treated with surgical reconstruction of the coracoclavicular ligament using tendon grafts. Both autografts and allografts are widely utilized, with no clear consensus on the superior option. Autografts, such as hamstring tendons, provide favorable outcomes but are associated with donor-site morbidity, whereas allografts offer an alternative without harvesting morbidity but may introduce complications such as osteolysis and immune-mediated tissue rejection. The choice between these grafts remains a topic of debate. This systematic review and meta-analysis aim to compare the clinical and radiological outcomes, complication rates, and donor-site morbidity of autograft vs. allograft tendon augmentation in chronic ACJ instability. Methods: A comprehensive search was conducted in PubMed, Embase, Cochrane, SportDiscus, and Web of Science until July 3, 2024. Studies were screened independently by two reviewers, with inclusion limited to English, Dutch, French, and German publications. Studies involving adults (≥18 years) with chronic ACJ dislocation (Rockwood type ≥ III) undergoing autograft or allograft reconstruction were included. Exclusion criteria encompassed biomechanical, cadaveric studies, and studies lacking separate outcome reporting for graft types. Data extraction was performed using standardized templates and analyzed with RStudio. Functional, radiological, and complication outcomes were pooled using random-effects models. Study quality was assessed using the Methodological Index for Non-Randomized Studies criteria and Cochrane Risk of Bias Tool. Results: = .009). Autografts showed higher donor-site morbidity and infection rates, while allografts were more frequently associated with osteolysis and acromioclavicular arthritis. Conclusion: Both autograft and allograft tendon augmentation provide comparable functional outcomes for chronic ACJ instability. During graft selection, one should consider patient-specific factors, weighing donor-site morbidity against potential allograft-related complications. Further standardized, high-quality research is required to guide optimal treatment selection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.